Pankaj Grover and Abhisek Gupta Launch Open Offer for Genomic Valley Biotech
Genomic Valley Biotech Ltd · Others (Uncategorized) · 03 Nov 2026, 11:45 pm
Pankaj Grover and Abhisek Gupta Launch Open Offer for Genomic Valley Biotech Pankaj Grover and Abhisek Gupta announced a mandatory open offer to acquire up to 7,94,170 equity shares, representing 26% of the voting share capital of Genomic Valley Biotech Ltd, at ₹30 per share in cash, aggregating to ₹2.38 cr. This follows an underlying share purchase agreement dated 19th Oct'26 to acquire 14,07,000 shares (46.06% stake) at ₹30 per share for ₹4.22 cr, triggering a management control change. The tendering period is scheduled from 14th Dec'26 to 28th Dec'26, with completion targeted by 11th Jan'27.
Original exchange filing (PDF)
More announcements from Genomic Valley Biotech Ltd
- Please find enclosed herewith unaudited standalone financial results for the quarter and half yearly ended on September 30, 2026 · 30 Oct 2026
- Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation, 2015 held on today i.e. 30th October 2026 · 30 Oct 2026
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation .... · 27 Oct 2026
- Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the unaudited financial .... · 30 Oct 2026
- Disclosure under Regulation 30 and Regulation 30A of the SEBI (LODR) Regulations, 2015 regarding Mr. Yogesh Agrawal (hereinafter referred to as the "Promoters" or "Promoter Sellers") of .... · 20 Oct 2026
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement ("PA") under Regulation 3(1) and Regulation 4 read with Regulation .... · 19 Oct 2026
- Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026, pursuant to regulation 30 of SEBI (Listing .... · 31 Aug 2026
- Unaudited financial results for Quarter ended on 30 June 2026. · 14 Aug 2026
